Fathom Therapeutics
a leading drug design company pioneering the application of quantum chemistry, physics-based molecular simulations, and artificial intelligence to discover and develop next-generation small molecule medicines
Amount raised
$55M
Round
Series A
Date raised
November 6, 2026
Founded
—
CompanyFathom Therapeutics
InvestorsSutter Hill Ventures
Founders
- Huafeng XuCo-founder and Chief Executive Officer
- Yujie WuCo-founder & Chief Technology Officer
- Jesús IzaguirreCo-founder
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Fathom Therapeutics
a leading drug design company pioneering the application of quantum chemistry, physics-based molecular simulations, and artificial intelligence to discover and develop next-generation small molecule medicines
- How much did Fathom Therapeutics raise?
- Fathom Therapeutics raised $55M in a Series A round on November 6, 2026. Investors include Sutter Hill Ventures.
- Who founded Fathom Therapeutics?
- Huafeng Xu and Yujie Wu and Jesús Izaguirre co-founded Fathom Therapeutics.